Kingdon Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-946,987
Closed -$3.05M 157
2017
Q2
$3.05M Sell
946,987
-851,508
-47% -$2.41M 0.26% 78
2017
Q1
$5.11M Sell
1,798,495
-218,335
-11% -$525K 0.39% 73
2016
Q4
$4.7M Buy
2,016,830
+390,092
+24% +$743K 0.32% 99
2016
Q3
$2.73M Buy
1,626,738
+347,870
+27% +$426K 0.18% 98
2016
Q2
$1.34M Sell
1,278,868
-34,380
-3% -$33.2K 0.11% 95
2016
Q1
$1.14M Sell
1,313,248
-710,620
-35% -$688K 0.09% 101
2015
Q4
$2.45M Buy
2,023,868
+58,130
+3% +$80.9K 0.18% 102
2015
Q3
$3.34M Buy
1,965,738
+300,000
+18% +$588K 0.27% 98
2015
Q2
$3.46M Buy
1,665,738
+500,000
+43% +$1.21M 0.2% 108
2015
Q1
$3.16M Hold
1,165,738
0.19% 128
2014
Q4
$3M Hold
1,165,738
0.16% 123
2014
Q3
$2.13M Hold
1,165,738
0.14% 142
2014
Q2
$3.1M Sell
1,165,738
-325,000
-22% -$978K 0.16% 156
2014
Q1
$5.2M Sell
1,490,738
-313,362
-17% -$1.39M 0.36% 104
2013
Q4
$8.06M Buy
1,804,100
+1,229,100
+214% +$5.01M 0.57% 84
2013
Q3
$2.33M Buy
575,000
+75,000
+15% +$328K 0.17% 154
2013
Q2
$2.06M Buy
+500,000
New +$1.93M 0.18% 165

Other funds holding ATRS